BMJ  2008;336:1416-1420 (21 June), doi:10.1136/bmj.39542.509444.AE (published 16 June 2008)

Research

Effect of 50 000 IU vitamin A given with BCG vaccine on mortality in infants in Guinea-Bissau: randomised placebo controlled trial

Christine Stabell Benn, senior researcher1, Birgitte Rode Diness, clinician1, Adam Roth, clinician1,2, Ernesto Nante, clinician3, Ane Bærent Fisker, student3, Ida Maria Lisse, senior registar 4, Maria Yazdanbakhsh, professor 5, Hilton Whittle, professor 6, Amabelia Rodrigues, research director3, Peter Aaby, director3

1 Bandim Health Project, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark , 2 Department of Medical Microbiology, Lund University, 205 02 Malmö, Sweden , 3 Bandim Health Project, Indepth Network, Apartado 861, Bissau, Guinea-Bissau , 4 Department of Pathology, Herlev University Hospital, 2730 Herlev, Denmark , 5 Department of Immunoparasitology, Leiden University Medical Centre, Leiden 2333 AZ, Netherlands , 6 MRC Laboratories, Fajara, POB 273, Gambia

Correspondence to: C S Benn cb{at}ssi.dk

Objective To investigate the effect of high dose vitamin A supplementation given with BCG vaccine at birth in an African setting with high infant mortality.

Design Randomised placebo controlled trial.

Setting Bandim Health Project’s demographic surveillance system in Guinea-Bissau, covering approximately 90 000 inhabitants.

Participants 4345 infants due to receive BCG.

Intervention Infants were randomised to 50 000 IU vitamin A or placebo and followed until age 12 months.

Main outcome measure Mortality rate ratios.

Results 174 children died during follow-up (mortality=47/1000 person-years). Vitamin A supplementation was not significantly associated with mortality; the mortality rate ratio was 1.07 (95% confidence interval 0.79 to 1.44). The effect was 1.00 (0.65 to 1.56) during the first four months and 1.13 (0.75 to 1.68) from 4 to 12 months of age. The mortality rate ratio in boys was 0.84 (0.55 to 1.27) compared with 1.39 (0.90 to 2.14) in girls (P for interaction=0.10). An explorative analysis revealed a strong interaction between vitamin A and season of administration.

Conclusions Vitamin A supplementation given with BCG vaccine at birth had no significant benefit in this African setting. Although little doubt exists that vitamin A supplementation reduces mortality in older children, a global recommendation of supplementation for all newborn infants may not contribute to better survival.

Trial registration Clinical trials NCT00168597 [ClinicalTrials.gov] .


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Articles

Key opinion leaders, your time is up
Fiona Godlee
BMJ 2008 336: 0. [Extract] [Full Text]

Vitamin A supplements in newborns and child survival
James M Tielsch
BMJ 2008 336: 1385-1386. [Extract] [Full Text] [PDF]

Randomised study of effect of different doses of vitamin A on childhood morbidity and mortality
Christine Stabell Benn, Cesario Martins, Amabelia Rodrigues, Henrik Jensen, Ida Maria Lisse, and Peter Aaby
BMJ 2005 331: 1428-1432. [Abstract] [Full Text] [PDF]

Impact of supplementing newborn infants with vitamin A on early infant mortality: community based randomised trial in southern India
Lakshmi Rahmathullah, James M Tielsch, R D Thulasiraj, Joanne Katz, Christian Coles, Sheela Devi, Rajeesh John, Karthik Prakash, A V Sadanand, N Edwin, and C Kamaraj
BMJ 2003 327: 254. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Tielsch, J. M (2008). Vitamin A supplements in newborns and child survival. BMJ 336: 1385-1386 [Full text]  



Student BMJ

Sepsis

The latest guidlines will affect how we practice medicine

www.student.bmj.com

Listen to the latest BMJ Interview